长链非编码RNA C9ORF139靶向miR-24-3P/TAOK1调控急性髓系白血病细胞增殖的作用和机制

来源 :中华医学杂志 | 被引量 : 0次 | 上传用户:tulip126
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:探讨长链非编码RNA(lncRNA)C9ORF139靶向微小RNA(miR)-24-3P/TAOK1调控急性髓系白血病(AML)细胞增殖的作用和机制。方法:AML细胞株(人急性早幼粒白血病细胞株HL-60以及人单核白血病细胞株THP-1)购自中国科学院,分为4组:A组为阴性对照(siNC)组,B组为干扰C9ORF139(siC9ORF139)组,C组为siC9ORF139+miR-24-3P抑制剂组,D组为miR-24-3P+TAOK1过表达(oe-TAOK1)组。采用实时荧光定量逆转录(qRT)-PCR检测4组AML细胞株HL-60、THP-1中的表达水平。细胞计数试剂盒-8(CCK8)法检测细胞增殖,流式细胞仪分析细胞的凋亡情况,Transwell实验检测4组细胞的迁移、侵袭能力,Western印迹法检测p-丝氨酸/苏氨酸激酶(p-raf)、p-丝裂原活化蛋白激酶(p-MEK)、p-细胞外调节蛋白激酶(p-ERK)表达。构建荧光素酶报告基因质粒,验证C9ORF139、miR-24-3P、TAOK1的结合能力。裸鼠皮下肿瘤细胞接种分为HL-60(A组)和HL-60(B组)。结果:敲减细胞中C9ORF139基因并培养120 h后,在HL-60及THP-1细胞中,B组细胞增殖能力(0.62±0.02、0.82±0.02)、迁移能力(0.22±0.03、0.05±0.01)、侵袭能力(0.20±0.02、0.13±0.03)均低于A组(1.30±0.02、1.83±0.07;0.99±0.02、0.99±0.02;1.00±0.01、1.00±0.01)(均n P<0.05)。共转染miR-24-3抑制剂后,细胞增殖能力、迁移能力、侵袭能力均高于B组(均n P<0.05)。共转染miR-24-3P与oe-TAOK1质粒后,细胞增殖能力、迁移能力、侵袭能力均高于B组(均n P<0.05)。当干扰细胞中C9ORF139基因后,与A组凋亡水平(0.31±0.27、2.49±0.33)相比,B组(28.56±8.07、17.74±1.91)均较高(均n P<0.05);当共转染miR-24-3P抑制剂后,C组细胞凋亡水平(2.34±0.09、3.06±0.06)均低于B组(均n P<0.05);在共转染miR-24-3P与oe-TAOK1质粒组中,D组细胞凋亡水平(2.16±1.29、4.80±0.37)均低于B组(均n P<0.05)。在HL-60、THP-1细胞中,当C9ORF139未突变时,miR-24-3P组荧光素酶活性均低于miR-NC组(均n P0.05)。当TAOK1未突变时,miR-24-3P组荧光素酶活性低于miR-NC组(n P0.05)。当干扰HL-60细胞中C9ORF139基因并培养72 h后,B组Raf、MEK及ERK分子磷酸化表达水平均低于A组(均n P<0.05)。第14天,A组肿瘤体积高于B组[(284.49±57.61)比(125.70±18.64)mmn 3,n P=0.017]。HL-60 A组肿瘤重量高于B组[(847.80±159.36)比(408.40±113.16)mg,n P=0.001]。n 结论:lncRNA C9ORF139通过调控miR-24-3P上调TAOK1促进AML细胞的增殖、侵袭、迁移,C9ORF139表达具有促进AML裸鼠皮下肿瘤生长的作用。“,”Objective:To investigate the role and mechanism of long non-coding RNA (lncRNA) C9ORF139 targeting micro RNA(miR)-24-3P/TAOK1 in regulating the proliferation of acute myeloid leukemia (AML) cells.Methods:AML cells HL-60 and THP-1 were purchased from the Chinese Academy of Sciences and divided into 4 groups:group A was negative control group (siNC group), group B was interference C9ORF139 group (siC9ORF139 group), group C was siC9ORF139+miR-24-3p inhibitor group, and group D was miR-24-3P+TAOK1 overexpression group (oe-TAOK1 group). Real-time fluorescence quantitative reverse transcription PCR was used to detect the expression levels of AML cell lines of HL-60 and THP-1 in four groups. Cell Counting Kit-8 assay was performed to measure cell proliferation. Flow cytometry was applied to analyze cell apoptosis. Transwell test was applied to detect cell migration and invasion ability. Western blot was used to detect p-serine/threonine kinase (p-raf) and p-mitogen activation proteinkinase (p-MEK), p-extracellular regulatory protein kinase (p-ERK) expression. The luciferase reporter gene plasmid was constructed to verify the binding ability of C9ORF139,miR-24-3P and TAOK1.Nude mice were inoculated with subcutaneous tumor cells of HL-60 (group A) and HL-60 (group B).Results:After the C9ORF139 gene was knocked down and cultured for 120 h, The cell proliferation ability (0.62±0.02, 0.82±0.02), migration ability (0.22±0.03, 0.05±0.01), invasion ability (0.20±0.02, 0.13±0.03) of group B were all lower than that of group A (1.30±0.02, 1.83±0.07; 0.99±0.02, 0.99±0.02; 1.00±0.01, 1.00±0.01) (all n P<0.05). When co-transfected with miR-24-3 inhibitor, cell proliferation ability, migration ability and invasion ability were all higher in group B (alln P<0.05). When co-transfected with miR-24-3P and oe-TAOK1 plasmid, cell proliferation ability, migration ability and invasion ability were all higher than group B (alln P<0.05).When the C9ORF139 gene in the cells was knocked down, the apoptosis level of group B (28.56±8.07, 17.74±1.91) were higher than those of group A (0.31±0.27, 2.49±0.33)(alln P<0.05); when co-transfected with miR-24-3P inhibitor, the apoptosis level (2.34±0.09, 3.06±0.06) were lower than those in group B (alln P<0.05); when co-transfected with miR-24-3P and oe-TAOK1 in the plasmid group, the apoptosis level (2.16±1.29, 4.80±0.37) were also lower than those of group B (alln P<0.05). In HL-60 and THP-1 cells, when C9ORF139 was not mutated, the luciferase activity of miR-24-3P group was lower than that of the miR-NC group (n P0.05).When TAOK1 was not mutated; the luciferase activity of miR-24-3P group was lower than that of group A (n P0.05).When the C9ORF139 gene in HL-60 cells was knocked down and cultured for 72 h, the phosphorylation expression levels of Raf, MEK and ERK molecules in group B were significantly lower than those in group A (all n P<0.05). By day 14, the tumor volume in the group A was greater than the tumor cell volume in the group B [(284.49±57.61) vs (125.70±18.64) mmn 3, n P=0.017]. The tumor weight of HL-60 in group A was heavier than that of group B [(847.80±159.36) vs (408.40±113.16) mg, n P=0.001].n Conclusions:LncRNA C9ORF139 regulates TAOK1 by sponging miR-24-3P to promote the proliferation, invasion and migration of acute myeloid leukemiacell.In vivo experiments have confirmed that the expression of C9ORF139 can promote the growth of subcutaneous tumors in AML nude mice.
其他文献
本文报道了1例反复肺部感染、淋巴结肿大伴肝占位的患者,淋巴结活检、肝脏占位穿刺活检病理为炎性肉芽肿性病变伴非特异性坏死,DHR123流式细胞分析示中性粒细胞吞噬功能缺陷。全外显子测序显示患者CYBA基因存在c.7C>T(p.Gln3*)纯合突变,确诊患者为CYBA基因纯合突变所致的慢性肉芽肿病,予复方磺胺甲噁唑片口服。目前抗真菌治疗中,待情况稳定拟行干细胞移植。
肺切除术后脓胸合并支气管胸膜瘘病变复杂,治疗棘手,需采取个体化综合治疗。笔者团队采用彻底清创、气道内活瓣封堵、带蒂肌瓣填塞等多种方法联合,治疗了1例病史长达10年的慢性脓气胸合并支气管胸膜瘘的青年男性患者,取得了良好的治疗效果,使患者恢复了劳动能力。
β淀粉样蛋白(β-amyloid peptide,Aβ)在脑组织中沉积形成的淀粉样斑块是阿尔茨海默病(AD)的主要病理机制之一。β淀粉样前体蛋白(APP)经淀粉样降解产生Aβ。APP在内质网生成后的胞内转运过程极其复杂,其影响因素较多,本文综述了APP胞内转运路径,重点描述了糖基化、磷酸化、泛素化、脂质化以及结合蛋白对APP胞内转运的影响,意在从翻译后修饰、结合蛋白两个视角阐释APP胞内转运及其降解调节,以期进一步阐明AD的发生发展机制,并为AD干预和(或)治疗新策略提供思路。
报道2例青年卒中患者,病情好转后偏瘫侧不明原因出现关节疼痛伴活动受限,考虑为脑卒中后异位骨化,给予非甾体抗炎药、阿仑膦酸钠及康复治疗,症状体征明显好转,病变范围无扩大。该病国内报道少,应提高对疾病认识,早期干预,以免加重患者残疾。
肥胖是阻塞性睡眠呼吸暂停(OSA)的主要危险因素。短期的临床试验报道体重减轻可引起OSA严重程度的改善。接受积极干预的参与者体重减轻幅度越大,衡量OSA严重程度的指标——呼吸暂停低通气指数(AHI)的改善也越明显。但强化生活方式干预对OSA严重程度的长期影响仍不清楚。“Sleep AHEAD(Action for Health in Diabetes)”是一项针对患有2型糖尿病和超重肥胖的OSA患者的随机对照试验,比较以减肥为重点的强化生活方式干预(ILI)与糖尿病支持和教育(DSE)对OSA严重程度的影
期刊
本研究总结分析了54例IgG4相关性自身免疫性胰腺炎(IgG4-AIP)患者的超声造影表现,男40例,女14例,年龄26~76(59.1±10.2)岁。结果发现IgG4-AIP的超声造影增强模式呈多样化,有部分AIP患者尤其是肿块型AIP患者在疾病初期的超声造影表现与胰腺癌的超声造影表现有类似,在增强早期、增强晚期和延迟期均会有不同程度的低增强表现,因此仅靠超声造影表现对其进行鉴别诊断是不可取的,应综合评估。“,”To analyze and summarize the contrast-enhanced
副神经节瘤多表现为无痛性肿块,患者常以高血压为首发症状。若术前未能详细询问病史、完善相关检查及检验进行鉴别诊断,可能导致术前准备不足,从而使手术风险增加。本文报告了1例术前未能确诊的乙状结肠系膜巨大副神经节瘤的病例,通过术中给予酚妥拉明、术后给予去甲肾上腺素及补液等治疗,患者术后7 d好转出院。
报道1例以发热、肺间质病变起病,早期诊断多发性肌炎,随着病情进展,肺间质病变形态发生演变,并逐渐出现神经系统症状,最终诊断血管内大B细胞淋巴瘤的患者。需要提醒临床医生的是,多发性肌炎可能是一种副肿瘤综合征,在诊治过程中需要根据患者病情变化及时调整诊疗思路和方向。
为了探讨骨科机器人联合腕关节镜下植骨微创治疗无移位的Herbert D1型舟骨骨折的可行性和临床疗效,回顾性分析2019年12月至2021年1月在徐州仁慈医院接受天玑骨科机器人联合腕关节镜下植骨治疗的9例无移位的Herbert D1型舟骨骨折患者的临床资料。定期进行随访复查,评价骨折愈合情况,记录患者手术前及末次随访时握力、捏力,改良腕关节Mayo评分、腕关节疼痛视觉模量评分,并进行对比分析。本组9例患者平均随访14.1个月(7.5~24.0个月)。所有患者伤口均一期愈合,无感染等并发症,CT检查证实术后
阻塞性睡眠呼吸暂停(OSA)以独特的间歇性低氧、睡眠紊乱为病理生理表现,从动物实验到流行病学等多种研究方法不同程度阐明了OSA与常见慢性病的关联。多项回顾性或前瞻性队列研究探讨了OSA与肿瘤的共患关系,包括OSA患者中的肿瘤发病率、肿瘤患者中的OSA患病率以及OSA患者中的肿瘤死亡率,各项研究结果不一。多项研究显示OSA严重程度与肿瘤死亡率有关联,但二者的患病关系以及OSA与何种类型肿瘤关联尚不清楚。